CID 154699743

Losartan metabolite p1

Structural Information

Molecular Formula
C22H21ClN6O2
SMILES
CCCC(C1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C=O)Cl)O
InChI
InChI=1S/C22H21ClN6O2/c1-2-5-19(31)22-24-20(23)18(13-30)29(22)12-14-8-10-15(11-9-14)16-6-3-4-7-17(16)21-25-27-28-26-21/h3-4,6-11,13,19,31H,2,5,12H2,1H3,(H,25,26,27,28)
InChIKey
KMCNHKMBFGXFMW-UHFFFAOYSA-N
Compound name
5-chloro-2-(1-hydroxybutyl)-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carbaldehyde
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

436.14145 Da
Monoisotopic Mass

3.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 437.14873 201.0
[M+Na]+ 459.13067 210.7
[M-H]- 435.13417 205.2
[M+NH4]+ 454.17527 205.1
[M+K]+ 475.10461 201.4
[M+H-H2O]+ 419.13871 188.3
[M+HCOO]- 481.13965 211.6
[M+CH3COO]- 495.15530 208.4
[M+Na-2H]- 457.11612 198.4
[M]+ 436.14090 205.2
[M]- 436.14200 205.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.